Cite
HARVARD Citation
Leuci, V. et al. (2018). CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Leuci, V. et al. (2018). CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. p. . [Online].